Reduction of LDL-C-related residual cardiovascular risk with ezetimibe: are mechanistic considerations warranted in practice?

  • Karin H. Humphries, G.B. John Mancini
  • European Heart Journal, May 2017, Oxford University Press (OUP)
  • DOI: 10.1093/eurheartj/ehx275

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1093/eurheartj/ehx275

The following have contributed to this page: Karin Humphries